The ClinGen Evidence Repository is an FDA-recognized human genetic variant database containing expert-curated assertions regarding variants' pathogenicity and supporting evidence summaries. [Disclaimer]
  • No CSPEC related information was provided by the message!

  • See Evidence submitted by expert panel for details.

Variant: NM_001754.5(RUNX1):c.58+265G>A

CA14902411

1180228 (ClinVar)

Gene: RUNX1
Condition: hereditary thrombocytopenia and hematologic cancer predisposition syndrome
Inheritance Mode: Autosomal dominant inheritance
UUID: 550972e3-603e-4ec8-908a-79b6c5c018e5
Approved on: 2022-01-20
Published on: 2022-06-23

HGVS expressions

NM_001754.5:c.58+265G>A
NM_001754.5(RUNX1):c.58+265G>A
NC_000021.9:g.35048577C>T
CM000683.2:g.35048577C>T
NC_000021.8:g.36420874C>T
CM000683.1:g.36420874C>T
NC_000021.7:g.35342744C>T
NG_011402.2:g.941135G>A
ENST00000675419.1:c.58+265G>A
ENST00000300305.7:c.58+265G>A
ENST00000416754.1:c.58+265G>A
ENST00000437180.5:c.58+265G>A
ENST00000455571.5:c.58+265G>A
ENST00000475045.6:c.58+265G>A
ENST00000482318.5:c.58+265G>A
NM_001754.4:c.58+265G>A
More

Benign

Met criteria codes 4
BA1 BP7 BP2 BP4
Not Met criteria codes 22
PVS1 BS4 BS3 BS1 BS2 PP1 PP4 PP3 PP2 PM6 PM2 PM1 PM5 PM3 PM4 PS2 PS4 PS3 PS1 BP5 BP3 BP1

Evidence Links 0

Expert Panel

Criteria Specification Information

Criteria Specifications for this VCEP
Evidence submitted by expert panel
Myeloid Malignancy VCEP
Intronic variant with a MAF of 0.06181 (6.2%, 538/8704 alleles) in the African/African-American subpopulation of the gnomAD v2.1.1 cohort (≥ 0.0015 (0.15%)) (BA1). In addition, this variant is reported in 44 homozygotes in gnomAD v2.1.1 (BP2). Splice AI predicts no impact on splicing ≤ 0.20 (score: 0.00-0.06) (BP4). Intronic variants which SpliceAI ≤ 0.20 AND evolutionary conservation prediction algorithms predict the site as not conserved (phyloP100 way (GRCh38/hg38) ≤2.0). In summary, this variant meets criteria to be classified as benign. ACMG/AMP criteria applied, as specified by the Myeloid Malignancy Variant Curation Expert Panel for RUNX1: BA1, BP2, BP4 and BP7.
Met criteria codes
BA1
MAF of 0.06181 (6.2%, 538/8704 alleles) in the African/African-American subpopulation of the gnomAD v2.1.1 cohort is ≥ 0.0015 (0.15%).
BP7
Intronic variants which SpliceAI ≤ 0.20 AND evolutionary conservation prediction algorithms predict the site as not conserved (phyloP100 way -1.57148(GRCh38/hg38) ≤2.0).
BP2
This variant is reported in 44 homozygotes in gnomAD v2.1.1
BP4
Splice AI predicts no impact on splicing ≤ 0.20 (score: 0.00-0.06)
Not Met criteria codes
PVS1
N/A
BS4
N/A
BS3
No data currently available
BS1
Meets BA1
BS2
This rule is not applicable for MM-VCEP
PP1
N/A
PP4
This rule is not applicable for MM-VCEP
PP3
Splice AI predicts no impact on splicing (score: 0.00-0.06)
PP2
This rule is not applicable for MM-VCEP
PM6
N/A
PM2
Meets BA1
PM1
N/A
PM5
N/A
PM3
This rule is not applicable for MM-VCEP
PM4
N/A
PS2
N/A
PS4
Meets BA1
PS3
No data currently available
PS1
N/A
BP5
This rule is not applicable for MM-VCEP
BP3
This rule is not applicable for MM-VCEP
BP1
This rule is not applicable for MM-VCEP
Curation History
The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. If you have questions about the information contained on this website, please see a health care professional.
¤ Powered by BCM's Genboree.